Agios Pharma (AGIO) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Agios Pharma (AGIO) Company Statistics | The Fly

Agios Pharma

· AGIO

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

1.988 B

-0.15%

General

Market Cap: $1.99B
Enterprise Value: $1.92B
Shares Outstanding: 59,470,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 87.92%
Operating Margin: -466.78%
Net Profit Margin: -418.24%
FCF Margin: -371.43%
ROA: -37.11%
ROE: -35.67%
ROIC: -43.30%
Current Ratio: 10.22
Debt-to-Equity: 0.03
Revenue Per Employee: —

Valuation (TTM)

P/E: —
PEG: —
P/S: 20.19
P/FCF: —
P/B: 1.93
EV/EBITDA: -4.60

Growth

Rev 1Y: 48.03%
Rev 1Y Fwd Est: 237.80%
Rev 3Y (CAGR): 55.97%
Rev 5Y (CAGR): —
Rev 10Y (CAGR): -0.90%
EPS 1Y: -161.17%
EPS 1Y Fwd Est: —
EPS 3Y (CAGR): —

Income Statement (TTM)

Revenue: $98.34M
Gross Margin: 87.92%
Operating Expenses: $545.49M
Operating Income: -$459.02M
Net Profit: -$411.29M

Balance Sheet

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $99.65M
Working Capital: $647.45M
Total Assets: $1.11B
Net Debt: -$68.48M
Total Liabilities: $82.4M
Total Equity: $1.03B

Cash Flow Statement (TTM)

Cash Flow from Operations: -$360.6M
Cash Flow from Investing: $367.15M
Cash Flow from Financing: $12.22M
Free Cash Flow: -$365.25M
Capital Expenditures: $4.66M